Clinical Trial Update: Randomized, Double Blind Trial of Bromfenac BID (0.09%) as an Adjunct to Argon Laser Therapy in the Treatment of Diabetic Macular Edema. [Phase 4]

View source ↗

Summary

This Phase 4 randomized, double-blind study evaluated bromfenac 0.09% given twice daily as an adjunct to argon laser therapy for diabetic macular edema; the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• BROMFENAC (Bromfenac)

Snippet

Sponsor: Bp Consulting, Inc | Conditions: Diabetic Macular Edema | Phase 4 | Status: COMPLETED